VIPR2
MOLECULAR TARGETvasoactive intestinal peptide receptor 2
VIPR2 (vasoactive intestinal peptide receptor 2) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting VIPR2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Secretin | 1.61 | 4 |
| 2 | bdb vip ala15 | 1.10 | 2 |
| 3 | bdb vip ala19 | 1.10 | 2 |
| 4 | bdb vip ala9 | 1.10 | 2 |
| 5 | bdb nsc 0 cas 0 lys15 arg16 leu27 vip 1 7 grf 8 27 | 0.69 | 1 |
About VIPR2 as a Drug Target
VIPR2 (vasoactive intestinal peptide receptor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented VIPR2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
VIPR2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.